...
首页> 外文期刊>Pediatric Research >Exocrine Pancreatic Secretion in Rats Treated with Reserpine after Stimulation with Pilocarpine, Dopamine, and Caerulein
【24h】

Exocrine Pancreatic Secretion in Rats Treated with Reserpine after Stimulation with Pilocarpine, Dopamine, and Caerulein

机译:毛果芸香碱,多巴胺和青霉素刺激后利血平治疗大鼠的外分泌胰腺分泌

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Summary: Pancreatic juice was collected in vivo from control and reserpine-treted rats after stimulation with pilocarpine (0.2 mg/100 g body weight), dopamine (6-7 mg/100 g body weight), caerulein (90-100 pmole total dose) or with a combination of caerulein and secretin (6 u/100 g body weight) and the volume, amylase, bicarbonate and chloride outputs were compared. The results indicate that the secretory response to the three secretagogues was significantly reduced in the drug treated animals. Thus, the volumes of pancreatic juice were 57.0, 60.5, and 15.7% of those obtained in control rats after stimulation with, respectively, pilocarpine, dopamine, and caerulein. Amylase output was 63.8, 67.1, and 21.0% and bicarbonate output was 29.9, 46.8, and 6.2% of those observed in untreated rats after the same stimulants. Fluid secretion increased in the treated animals to 71.3% of that of controls when both caerulein and secretin were administered together and amylase output became greater than in control rats (151%). However, bicarbonate output was still 55.2% of that of controls with this combined stimulation. It is concluded that chronic reserpine administration impairs exocrine pancreatic secretion and that this effect involves both the acinar and ductal portions of the gland. This impairment involves the physiologic responses of these two segments of the glandular epithelium to both neural and hormonal stimulants. These findings suggest that the exocrine pancreatic disturbance in reserpine-treated rats may be similar to that observed in cystic fibrosis (CF), and because the treated rat has been proposed as a model for the human disease, they suggest the use of this model as a test system for the study of the pancreatic secretory abnormality in CF.Speculation: Rats treated in a chronic fashion with reserpine secrete significantly smaller amounts of fluid, amylase, and bicarbonate in pancreatic juice than control animals, whether secretion is elicited by hormonal or neural stimulants. The abnormality in exocrine pancreatic function induced by the drug treatment involves, therefore, the acinar and ductal segments of the gland and is similar to the alteration seen in patients with CF.
机译:摘要:用毛果芸香碱(0.2 mg / 100 g体重),多巴胺(6-7 mg / 100 g体重),青霉素(总剂量为90-100 pmole)刺激后,从对照组和利血平治疗的大鼠体内收集胰腺汁)或结合使用青霉素和促胰液素(6 u / 100 g体重)的体积,淀粉酶,碳酸氢盐和氯化物的产量进行比较。结果表明在药物治疗的动物中对三种促分泌素的分泌反应显着降低。因此,分别用毛果芸香碱,多巴胺和青霉素刺激后,胰腺汁的体积分别是对照组大鼠的57.0%,60.5%和15.7%。相同刺激后,未处理大鼠的淀粉酶产量分别为63.8%,67.1%和21.0%,碳酸氢盐产量分别为29.9%,46.8和6.2%。当同时施用caerulein和促胰液素并且淀粉酶输出变得比对照组大鼠大(151%)时,治疗动物的体液分泌增加到对照组的71.3%。然而,在这种联合刺激下,碳酸氢盐的产量仍然是对照的55.2%。结论是长期利血平给药会损害外分泌胰腺分泌,并且这种作用涉及腺体的腺泡和导管部分。这种损伤涉及腺上皮的这两部分对神经和激素刺激物的生理反应。这些发现表明,利血平治疗大鼠的外分泌胰腺紊乱可能与囊性纤维化(CF)中观察到的类似,并且由于已提议将治疗大鼠作为人类疾病的模型,因此他们建议将该模型用于推测:用利血平长期治疗的大鼠胰腺液中的液体,淀粉酶和碳酸氢盐的分泌量要比对照动物小得多,无论其分泌是激素分泌还是神经分泌引起的兴奋剂。因此,药物治疗引起的外分泌胰腺功能异常涉及腺体的腺泡和导管节段,与CF患者的变化相似。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号